Skip to main content
The Journal of Clinical Endocrinology and Metabolism logoLink to The Journal of Clinical Endocrinology and Metabolism
. 2025 Aug 8;110(10):e3550. doi: 10.1210/clinem/dgaf442

Correction to: “Approach to the Patient With Metastatic Pheochromocytoma and Paraganglioma”

PMCID: PMC12448570  PMID: 40795363

In the above-named article by Alkaissi H, Taieb D, Lin FI, Del Rivero J, Wang K, Clifton-Bligh R, and Pacak K (J Clin Endo Metab. 2025; doi: 10.1210/clinem/dgaf259), there was an error in the Disclosures section.

In the above-mentioned article, in the Disclosures section, the first sentence originally read, “H.A., D.T., F.I.L., J.D.R., K.W., R.C.B., and K.P. have nothing to disclose.” In the corrected article, “D.T.” was removed and the first sentence now reads, “H.A., F.I.L., J.D.R., K.W., R.C.B., and K.P. have nothing to disclose.” In the corrected article, before the original third sentence, “D.T. is a cofounder, stakeholder, and the chief medical officer (CMO) of SILON Therapeutics” has been included.

The article has been corrected online.

doi: 10.1210/clinem/dgaf259


Articles from The Journal of Clinical Endocrinology and Metabolism are provided here courtesy of The Endocrine Society

RESOURCES